CD8A and neoplasm: Koch et al. demonstrated a tumor-specific activation and cytotoxic activity of CD8+ tumour infiltrating lymphocytes (TIL) against tumor antigens in early CRC and several authors had already reported a down-regulation of CD8 activation and infiltration in advanced CRC [19, 28–30].